Get started
Author

Marie T. Evans

Observed names: M. T. Evans, M.T Evans, M.T. Evans
OpenAlex ID: A5109902950
Phase II Study of Vinorelbine in Patients With Malignant Pleural Mesothelioma
2000 · Jeremy P. C. Steele, Jonathan Shamash, et al. · Journal of Clinical Oncology · 203
Statistical Validation of the EORTC Prognostic Model for Malignant Pleural Mesothelioma Based on Three Consecutive Phase II Trials
2004 · Dean A. Fennell, Amit Parmar, et al. · Journal of Clinical Oncology · 109
Prognostic factors in mesothelioma
2005 · Jeremy P.C. Steele, Astero Klabatsa, et al. · Lung Cancer · 63
Expression and prognostic significance of hypoxia-inducible factor 1α (HIF-1α) in malignant pleural mesothelioma (MPM)
2005 · A. Klabatsa, M.T. Sheaff, et al. · Lung Cancer · 53
Phase II trial of vinorelbine and oxaliplatin as first-line therapy in malignant pleural mesothelioma
2004 · Dean A. Fennell, Jeremy P. C. Steele, et al. · Lung Cancer · 47
Efficacy and safety of first‐ or second‐line irinotecan, cisplatin, and mitomycin in mesothelioma
2006 · Dean A. Fennell, Jeremy P.C. Steele, et al. · Cancer · 46
Phase II trial of liposomal daunorubicin in malignant pleural mesothelioma
2001 · J.P.C. Steele, C.A. O’Doherty, et al. · Annals of Oncology · 35
PDF
Identification of glucose transporter type 1 overexpression as a predictor of survival in patients with malignant pleural mesothelioma
2004 · D. A. Fennell, A. Klabatsa, et al. · Journal of Clinical Oncology · 5
Phase II trial of vinorelbine and oxaliplatin in patients with malignant pleural mesothelioma
2000 · J.P.C Steele, J Shamash, et al. · Lung Cancer · 5
P-517 A phase II study of irinotecan, cisplatin, and mitomycin C (IPM) in malignant pleural mesothelioma
2003 · Dean A. Fennell, Jeremy P.C. Steele, et al. · Lung Cancer · 4
Vinorelbine (Navelbine) given as a single agent for malignant pleural mesothelioma. Results from 65 patients at a single centre
2000 · J.P.C Steele, J Shamash, et al. · Lung Cancer · 4
P-518 Second line therapy of malignant pleural mesothelioma with irinotecan, cisplatin, and mitomycin C (IPM): A phase II study
2003 · Dean A. Fennell, Jeremy P.C. Steele, et al. · Lung Cancer · 3
O-30 Statistical validation of the EORTC prognostic model for malignant pleural mesothelioma based on three consecutive phase II trials
2003 · Dean A. Fennell, Amit Parmar, et al. · Lung Cancer · 3
P-516 Expression and prognostic significance of hypoxia-inducible factor 1 alpha in malignant pleural mesothelioma
2003 · Dean A. Fennell, Astero Klabatsa, et al. · Lung Cancer · 1
58 A phase II study of interleukin-2 in malignant pleural mesothelioma
1997 · C.W. Mulatero, R.T. Penson, et al. · Lung Cancer · 1
P-577 Treatment of relapsed small cell lung cancer with irinotecan, cisplatin, and mitomycin C (IPM): A phase II study
2003 · Dean A. Fennell, Sarah E. Slater, et al. · Lung Cancer
Phase I I S tudy o f V inorelbine i n P atients W ith M alignant Pleural M esothelioma
2000 · Jonathan Shamash, Marie T. Evans, et al.
265 A phase II study of doxorubicin and cisplatin in malignant pleural mesothelioma
1997 · R.T. Penson, C.W. Mulatero, et al. · Lung Cancer
Works count: 18
Citation count: 582
H-index: 7
I10-index: 7
Year
Topic
Type